Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 9/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 3/20 | 0.34 |
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | RXRB | P28702 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116561 | 0.93 | ICMT (0.38) | ICMTKIF11RXRARXRBHSP90AA1 | |
| SCHEMBL21116283 | 0.92 | KIF11 (0.40) | ICMTKIF11TACR1RXRARXRB | |
| SCHEMBL21116889 | 0.91 | KIF11 (0.41) | KIF11HSP90AA1KDM4EATML3MBTL1 | |
| SCHEMBL21116900 | 0.89 | KIF11 (0.46) | KIF11HSP90AA1KDM4EATML3MBTL1 | |
| SCHEMBL21116344 | 0.88 | TSPO (0.40) | KIF11RXRARXRBKDM4EATM | |
| SCHEMBL26534941 | 0.86 | ICMT (0.40) | ICMTRXRARXRBKDM4EL3MBTL1 | |
| SCHEMBL21131432 | 0.86 | ICMT (0.37) | ICMTKIF11TACR1RXRARXRB | |
| SCHEMBL21116492 | 0.85 | L3MBTL1 (0.40) | KIF11KDM4EATML3MBTL1PTGES | |
| SCHEMBL21116489 | 0.85 | L3MBTL1 (0.40) | KIF11KDM4EATML3MBTL1PTGES | |
| SCHEMBL21116284 | 0.85 | RXRA (0.37) | ICMTKIF11RXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | ICMT 2503/4885KIF11 3544/4885TACR1 1273/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | ICMT 2637/4885KIF11 3520/4885TACR1 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.